Gracell Biotechnologies Inc - ADR

NASDAQ:GRCL   3:59:54 PM EDT
13.95
+0.35 (+2.57%)
Earnings Announcements

Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results

Published: 08/17/2021 11:13 GMT
Gracell Biotechnologies Inc - ADR (GRCL) - Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corporate Update.
Gracell Biotechnologies Inc Qtrly Loss per Share $0.04.
Gracell Biotechnologies Inc - As of June 30, 2021, Had $318.1 Million in Cash and Cash Equivalents and Short-term Investments.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.